Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bausch + Lomb Corporation ( (BLCO) ) has provided an announcement.
Bausch + Lomb has launched the Arise Orthokeratology Lens System in the United States, a cloud-based platform designed to streamline the orthokeratology lens fitting process for treating myopia. This innovative system, which is the first of its kind approved by the FDA for overnight use with toric peripheral curves, aims to enhance efficiency and precision for eye care professionals by reducing fitting time and providing secure access to patient data.
More about Bausch + Lomb Corporation
Bausch + Lomb Corporation is a leading global eye health company dedicated to improving vision and enhancing quality of life. The company focuses on developing innovative eye care solutions, including contact lenses and lens care products, to address various ocular conditions and improve visual health worldwide.
YTD Price Performance: -14.72%
Average Trading Volume: 594,181
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.41B
See more insights into BLCO stock on TipRanks’ Stock Analysis page.